REDHILL BIOPHARMA LTD. Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement
REDHILL BIOPHARMA LTD. (RDHL) reported Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement of $0.02 for the 12-month period ending 2018-12-31, per its 20-F filed 2019-02-26.
Discontinued › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement · last filed 2019-02-26
| Period end | Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement 12 month |
|---|---|
| 2018-12-31 | $0.02 20-F · filed 2019-02-26 |
| 2017-12-31 | $0.27 20-F · filed 2019-02-26 |
| 2016-12-31 | $0.36 20-F · filed 2018-02-22 |